Showing entries 1 to 3 of 57
A brief study showing a novel way of introducing the Dystrophin gene into mdx mice is followed by a review on the potential of the use of non-viral vectors for transferring the dystrophin gene.
An analysis of the characteristics of DMD cases is presented, which demonstrate great heterogeneity, which needs to be taken in consideration when planning clinical trials.
Speculations about Gene-doping to enhance athletic abilities have been discussed for many years. The value of such studies for the treatment of DMD is assessed.